Evidence map›Paper›PMID 41991891›Full record

ArticleAnnals of surgical oncology2026

ASO Author Reflections: Geographic Variation and Universal Challenges in the Patient Experience with Invasive Lobular Carcinoma.

Claire E Fanning, Jacqueline S Jeruss

Abstract read
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claire E FanningUniversity of Michigan Medical School, Ann Arbor, MI, USA.
Jacqueline S JerussUniversity of Michigan Medical School, Ann Arbor, MI, USA. jjeruss@med.umich.edu.

Funding

Tissue engineering tools for monitoring the cellular and molecular response to therapyR01CA272940 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JACQUELINE SARA JERUSS, Lonnie D Shea · 2023 to 2026
$1.7M
Nanoparticles to reprogram innate immune cells and disrupt the metastatic nicheR01EB036030 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JACQUELINE SARA JERUSS, Lonnie D Shea · 2024 to 2026
$1.5M
Injectable scaffolds for early detection of immune dysregulation and monitoring response to immunotherapiesU01EB036955 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JACQUELINE SARA JERUSS, Lonnie D Shea · 2025 to 2026
$1.1M
CLC NIH HHS R01CA272940CLC NIH HHS U01EB036955NIH HHS R01EB036030
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41991891
PMCPMC13242404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.